ALSO NOTED: Ariad selling shares; Indevus gains milestone; Barr closing on Pliva; and much more...

> Ariad Pharmaceuticals is selling 3.1 million shares in a public offering. Report

> Indevus Pharmaceuticals has received a $10 million milestone payment from Esprit Pharma, the company's partner in the U.S. for Sanctura and and Sanctura XR. Release

> Barr Pharmaceuticals has now acquired 92 percent of Pliva's shares, putting it on track to close the takeover next month. Report

> Dutch biotech AM-Pharma is touting positive results for its pilot study in treating sepsis with its Alkaline Phosphatase drug. Release

And Finally… Scientists helped add 30 years to the average life span over the past century. Now they're focusing on adding vitality to a longer life. Report